Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Teva plans to raise Mylan bid by as much as $2 billion: Bloomberg | Reuters
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
ADHD Drug Adderall Supply Delays Likely to Continue for 2-3 Months, Teva Says - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Tags search | Ctech
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva makes $40B offer for Mylan
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg
Drugmaker Teva makes $40B bid for rival Mylan
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
